Nexalis Therapeutics Limited (ASX:NX1)
0.0230
-0.0010 (-4.17%)
At close: May 29, 2026
-14.81% (1Y)
| Market Cap | 5.82M -38.7% |
| Revenue (ttm) | 986.43K +145.5% |
| Net Income | -1.62M |
| EPS | -0.01 |
| Shares Out | 253.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 175,912 |
| Open | 0.0200 |
| Previous Close | 0.0240 |
| Day's Range | 0.0160 - 0.0230 |
| 52-Week Range | 0.0160 - 0.0480 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |